GTBIF · Green Thumb Industries Inc.
Market Cap
$1.49B
Shares
197.58M
GTBIF metrics
90 of 114 screener metrics currently available.
Market overview
2 metricsShare price
$7.48
Market cap
$1.49B
Price action
19 metricsPrice change (1W)
-0.7%
Price change (30D)
+3.6%
Price change (3M)
-1.6%
Price change (6M)
+15.8%
Price change (YTD)
-6.3%
Price change (1Y)
-14.4%
Trailing year
Price change (5Y)
-73.9%
52-week high
$9.70
52-week low
$5.29
Change from 52-week high
-22.3%
Change from 52-week low
+42.3%
Annualized volatility
90.0%
Beta
1.0
RSI (14D)
54.2
Price vs SMA 50
+3.2%
Price vs SMA 200
+4.2%
Avg volume (3M)
534,639
Relative volume
1.6
Average dollar volume
$4.01M
Company
3 metricsSector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Shares outstanding
197.58M
Valuation
12 metricsP / E (TTM)
18.4
Trailing earnings · reciprocal yield 5.4%
PEG ratio
0.3
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
1.2×
reciprocal yield 81.3%
P / book
0.8
reciprocal yield 124.9%
FCF yield
13.3%
TTM · current market cap
Buyback yield
—
P / FCF
7.5
reciprocal yield 13.3%
P / operating cash flow
5.5
reciprocal yield 18.1%
Earnings yield
8.5%
Historical valuation
8 metricsP / E historical average (3Y)
64.2×
reciprocal yield 1.6%
P / E historical average (5Y)
111.8×
reciprocal yield 0.9%
EV / revenue historical average (3Y)
1.3×
reciprocal yield 79.1%
EV / revenue historical average (5Y)
1.3×
reciprocal yield 79.1%
EV / EBIT historical average (3Y)
9.2×
reciprocal yield 10.9%
EV / EBIT historical average (5Y)
9.2×
reciprocal yield 10.9%
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
2026-08-04
Profitability
9 metricsGross margin
46.9%
Operating margin
9.6%
Trailing 12 months
Net margin
10.5%
Gross profit (TTM)
$566.88M
Operating profit (TTM)
$116.49M
Net income (TTM)
$126.77M
Trailing 12 months
Diluted EPS (TTM)
$0.41
FCF margin
16.4%
Effective tax rate
55.3%
Growth
11 metricsRevenue growth YoY
+4.6%
Year over year
Net income growth YoY
+56.2%
Revenue (TTM)
$1.21B
Trailing 12 months
EPS growth YoY
+60.0%
Shares change YoY
-5.5%
Year over year · fewer shares
Revenue CAGR (3Y)
+4.9%
Revenue CAGR (5Y)
+16.1%
EPS CAGR (3Y)
+112.5%
EPS CAGR (5Y)
+47.0%
FCF CAGR (3Y)
—
FCF CAGR (5Y)
+42.7%
Quality
14 metricsReturn on equity
6.8%
Return on assets
4.5%
Debt / equity
—
Current ratio
2.9
EBITDA (TTM)
$268.44M
Free cash flow (TTM)
$197.77M
Quick ratio
2.0
Interest coverage
5.5
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$283.59M
Total assets
$2.82B
Total debt
$247.29M
Cash flow & spend
7 metricsOperating cash flow (TTM)
$269.07M
Capital expenditures (TTM)
$71.30M
R&D (TTM)
—
SG&A (TTM)
$450.39M
Stock compensation (TTM)
$43.79M
R&D / revenue
—
Stock compensation / revenue
3.6%
Ownership (13F)
3 metrics13F filers
5
13F filer change QoQ
0
Institutional ownership
0.2%
Short interest
3 metricsShort interest
0.1%
Latest settlement · 1.0 days to cover
Days to cover
1.0d
Short-squeeze score
39 / 100
Insider activity
2 metricsNet insider buying (90D)
−$37,853
Insider-sentiment score
56 / 100
Risk flags
1 metricsGoing concern
—